Connecting the Mechanisms of Action to Patient Outcomes: Integrating the Latest Treatments for T2D Into Patient Care

Expert faculty review the mechanism of action of SGLT2 inhibitors, GLP-1 receptor agonists, and GIP/GLP-1 coagonists, and describe how knowledge of these actions can be used to guide treatment for patients with T2D and overweight or obesity.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with the Endocrine Society.

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Endocrine Society

ProCE Banner